Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Therapeutic Advances in Neurological Disorders|March 27, 2025
Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravisYufan Zhou, Qian Zhou, Yaoxian Yue, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 17, 2026
Targeting pathogenic Th17.1 cells via JAK-STAT3 pathway: A novel approach with tofacitinib for refractory myasthenia gravisRui Zhao, Chong Yan, Huahua Zhong, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 1, 2026
Phospho-MLKL Upregulation in Immune-Mediated Necrotizing Myopathy: Implications for Disease Pathophysiology and DiagnosisMingshi Gao, Nachuan Cheng, Dongyue Yue, et al.Neurology and Therapy|June 27, 2026
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort StudyJialin Chen, Hongxi Chen, Xianglin Chu, et al.BMC Immunology|May 27, 2022
Increased serum IL-2, IL-4, IL-5 and IL-12p70 levels in AChR subtype generalized myasthenia gravisXiao Huan, Rui Zhao, Jie Song, et al.Journal of Human Genetics|December 27, 2018
Correction: GNE myopathy in Chinese population: hotspot and novel mutationsYang Chen, Jianying Xi, Wenhua Zhu, et al.Journal of Human Genetics|November 4, 2018
GNE myopathy in Chinese population: hotspot and novel mutationsYang Chen, Jianying Xi, Wenhua Zhu, et al.Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|October 1, 2019
Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle ChannelopathiesJian Sun, Sushan Luo, Jie Song, et al.Therapeutic Advances in Neurological Disorders|July 29, 2024
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case seriesJie Song, Xiao Huan, Yuanyi Chen, et al.Clinical Immunology (Orlando, Fla.)|December 18, 2025
Eculizumab as a new option for perioperative treatment in thymoma-associated myasthenia gravisHui Wu, Xianglin Chu, Huahua Zhong, et al.Pageof 11